MedTrace Logo

Novel Influenza A (H1N1) Surveillance Registry

NCT01046331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 894

Last updated 2016-04-14

No results posted yet for this study

Summary

The demographic characteristics, clinical features, course, and outcomes of severe H1N1 influenza infection requiring intensive care have not been defined rigorously and systematically. While the majority of patients in early reports of critically ill novel influenza A (H1N1) have respiratory involvement, up to 10-20% may present with non-respiratory organ failures, such as shock, seizures, or acute renal failure. The burden of disease and resource utilization of these patients remains largely unknown. The purpose of this surveillance registry is to characterize the demographics, clinical features, outcomes, and resource utilization of patients with H1N1 influenza infection who require intensive care.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • B. Taylor Thompson, MD · Massachusetts General Hospital

  • Adrienne G Randolph, MD, MSc · Boston Children's Hospital

  • Todd W Rice, MD, MSc · Vanderbilt University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-04-30
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01046331 on ClinicalTrials.gov